Rollerblade Recall Issued Due To Defective Frames
A recall has been issued for roughly 11,800 pairs of Rollerblades, due to a risk of problems with the inline skates where the mounting holes in the boot and frame may be misaligned, potentially posing a fall hazard for consumers.
The Rollerblade recall was announced by the U.S. Consumer Product Safety Commission (CPSC) on February 25, impacting the Tempest Inline model of skates.
Although no injuries have been reported in connection with the Rollerblades to date, the manufacturer has acknowledged that a defect in the skates may cause the boot to separate from the frame, which may cause users to fall.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
The recall includes both men and women’s Rollerblade Tempest skates, which are designed for high performance training or racing. The skates are equipped with four wheels and a silver aluminum frame that attaches to a boot. The skates have the name brand name “Rollerblade” printed in several areas on the boot and the model name “Tempest” printed on the back of the cuff. The recall includes particular 90 and 100 models for both men and women.
The recalled skates were manufactured in Thailand under Rollerblade USA LLC of West Lebanon, New Hampshire, where they were sold at Blades, Paragon, Peter Glenn, Play it Again Sports, Summit Sports, and other various sporting goods stores nationwide, as well as online at Amazon.com, InlineWarehouse.com, and REI.com from December 2010 through January 2014 for between $350 and $450.
The CPSC recommends that customers with recalled skates stop using them immediately and contact Rollerblade USA at 800-232-7655 or by visiting them online at www.rollerblade.com to receive instructions on how to receive a free inspection and free replacement if the mounting holes are misaligned. Customers may also contact the company by email at RCS@Rollerblade.com.
"*" indicates required fields
More Top Stories
The FDA has announced it has received 106,000 medical device reports linked to recalled Philips CPAP devices, including nearly 400 deaths.
The U.S. JPML has consolidated all Tepezza lawsuits over hearing loss before one Northern Illinois federal judge for coordinated pretrial proceedings.
Bard claims two cases selected for the third and fourth bellwether trials are no longer representative of the litigation due to the plaintiffs' worsening injuries and need for additional surgeries due to their failed hernia mesh products.